Viewing nowCombinationStaphorzi 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.

MFDS item code 201308482 · Approved 2013.07.30 · Insurance code 657202550
Improvement of blood pressure control in essential hypertension
This medication can be used to achieve more effective blood pressure control in cases where either Amlodipine or Valsartan monotherapy is insufficient for blood pressure management due to essential hypertension.
The recommended dosage of this medication is one tablet once daily, taken with water regardless of meals. It is advised to take it at the same time every day (e.g., in the morning). The medication can be administered as required for patients who have difficulty controlling blood pressure at doses of 5/80 mg, 5/160 mg, or 10/160 mg. Dosage adjustments and precautions are required for patients with renal impairment, hepatic impairment, or elderly patients.
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, and its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Individuals who are allergic to any components of this medication or similar drugs, pregnant or possibly pregnant women, and nursing mothers should not take this medication. Patients with severely impaired kidney function, liver function issues, a history of certain heart diseases, or vascular edema should not use this medication for safety reasons. Patients who have low sodium or fluid levels in their body may experience hypotension; therefore, it is essential to monitor the condition before use and take this medication under the observation of a physician. Frequent monitoring of potassium levels is necessary for patients with high potassium levels or those taking potassium supplements. The safety of this medication has not been sufficiently established in kidney transplant patients, thus cautious use is required. If symptoms of angioedema occur during treatment, the medication should be discontinued immediately, and it should not be readministered. Patients after heart failure or myocardial infarction should closely monitor kidney function and blood pressure while taking this medication. Patients with acute myocardial infarction or certain cardiac valve diseases require caution when using this medication. This medication may increase the risk of side effects when combined with other blood pressure-related medications, so concomitant use is not recommended. While taking this medication, dizziness or fatigue may occur, so caution is advised when driving or operating machinery. In the case of overdose, hypotension or arrhythmias may occur, so it is essential to strictly adhere to the prescribed dosage, and if unusual symptoms arise, consult medical personnel immediately. The safety and efficacy of this medication have not been sufficiently established in children under 18 years of age, and its use is not recommended. In elderly patients, it can be administered at doses similar to those for adults, but their condition should be closely monitored. It is important to regularly monitor blood pressure, kidney function, and electrolyte levels for abnormalities during treatment.
Urticaria, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in the oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, visual disturbances,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture and kept at a temperature between 1 degree and 30 degrees Celsius. Proper storage preserves the medication's effectiveness over time.
Dark yellow rectangular film-coated tablets
28 tablets (14 tablets/PTP × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Hanin Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.